| SC 13D/A | 2024-02-08 | BROADWOOD PARTNERS, L.P. | Lineage Cell Therapeutics, Inc. | 41,666,255 | 22.1% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Lineage Cell Therapeutics, Inc. | 3,755,757 | 2.2% | EDGAR |
| SC 13D/A | 2022-03-25 | BROADWOOD PARTNERS, L.P. | Lineage Cell Therapeutics, Inc. | 34,935,485 | 20.6% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Lineage Cell Therapeutics, Inc. | 10,008,510 | 5.9% | EDGAR |
| SC 13D/A | 2021-03-16 | BROADWOOD PARTNERS, L.P. | Lineage Cell Therapeutics, Inc. | 34,005,379 | 21.0% | EDGAR |
| SC 13D/A | 2021-01-08 | Lineage Cell Therapeutics, Inc. | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2020-04-27 | Lineage Cell Therapeutics, Inc. | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2020-02-14 | GREENBELT CORP /NY | Lineage Cell Therapeutics, Inc. | 1,043,346 | 0.7% | EDGAR |
| SC 13D/A | 2020-01-06 | Lineage Cell Therapeutics, Inc. | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2019-09-13 | Lineage Cell Therapeutics, Inc. | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2019-07-05 | BIOTIME INC | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2019-03-12 | BROADWOOD PARTNERS, L.P. | BIOTIME INC | 33,728,991 | 22.3% | EDGAR |
| SC 13D/A | 2019-03-12 | BIOTIME INC | Asterias Biotherapeutics, Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2018-11-08 | BIOTIME INC | Asterias Biotherapeutics, Inc. | - | 39.2% | EDGAR |
| SC 13D/A | 2018-08-22 | BIOTIME INC | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2018-05-18 | BIOTIME INC | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2018-04-03 | BIOTIME INC | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2017-11-15 | BIOTIME INC | OncoCyte Corp | - | 13.0% | EDGAR |
| SC 13D/A | 2017-11-15 | BIOTIME INC | Asterias Biotherapeutics, Inc. | - | 40.2% | EDGAR |
| SC 13D/A | 2017-04-03 | BIOTIME INC | Asterias Biotherapeutics, Inc. | - | 44.4% | EDGAR |